Senior insider sale
Chief Executive Officer at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$1.81M
69K shares
What this filing means
COLOMA JASON V plans to sell 69K shares of MAZE THERAPEUTICS, INC. valued at approximately $1.81M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001969223-26-000612
DirectorOfficer· Chief Executive Officer
Since Mar 2026
69K
Shares to sell
$1.81M
Approx. market value
34.50K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months2
Gift
NA
9/22/2021
31.91KGift
NA
9/22/2021
2.59KTotal acquired34.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/22/2021 | Gift NA | 31.91K | Gift |
9/22/2021 | Gift NA | 2.59K | Gift |
| Total | 34.50K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
25.58K
Market value
$665.5K
5/26/2026
—Completed
Units to sell
2.48K
Market value
$64.4K
5/22/2026
—Completed
Units to sell
4.50K
Market value
$117.1K
5/22/2026
—Completed
Units to sell
116.00
Market value
$3.0K
5/15/2026
—Completed
Units to sell
1.82K
Market value
$47.4K
5/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
34.50K
Market value
$908.1K
6/1/2026
Total
Units
69K
Value
$1.81M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/26/2026 | 25.58K | $665.5K | — | Completed |
5/22/2026 | 2.48K | $64.4K | — | Completed |
5/22/2026 | 4.50K | $117.1K | — | Completed |
5/15/2026 | 116.00 | $3.0K | — | Completed |
5/15/2026 | 1.82K | $47.4K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 34.50K | $908.1K | Nasdaq | Planned |
| Total | 69K | $1.81M | ||